Australian Centre for Disease Control has recently published their analysis of adverse event following COVID-19 vaccination in Australia for 2021.
I am sharing few excerpts from the article in this 🧵
#Australia
#mRNA
#COVIDVACCINE
The COVID-19 AEFI reporting rate was 507.8
per 100,000 population, in people aged ≥ 12 years,
reflecting that many people received more than one
dose of vaccine. These reporting rates were markedly greater (38-fold) than the annual AEFI reporting rate for non-COVID-19 vaccines.
“The annual dose-based AEFI reporting rate was still greater than the annual AEFI reporting rate for non-COVID-19 vaccines of 30.6 per 100,000 doses (all ages) for the same year.”
#Australia
#mRNA
#COVIDVACCINE
"There was an increase in AEFI reports in people aged 16–59 years following Comirnaty from June, contemporaneous with the identification of myocarditis and pericarditis cases following Comirnaty vaccines."
#Australia
#mRNA
#COVIDVACCINE
"In the same month, ATAGI recommended preferential use of Comirnaty over Vaxzevria in people aged < 60 years due to increased risk of TTS, increasing Comirnaty uptake and associated AEFI reports in this age group.”
#Australia
#mRNA
#COVIDVACCINE
"Chest pain and other cardiorespiratory symptoms were more commonly reported (relative to other PT/
SMQ) in adolescents aged 12–15 years (Figure 3),
despite low rates of myocarditis following COVID-19
vaccines reported in this age group."
#Australia
#mRNA
#COVIDVACCINE
"Venous embolic and thrombotic events were in the
top twenty PT/SMQ for people aged ≥ 60 years."
"..this common event being temporally associated with a vaccination event when the whole population was being vaccinated."
#Australia
#mRNA
#COVIDVACCINE
The proportion of serious adverse events reported
following COVID-19 vaccination was consist-
ent between brands at around 14%, but was higher
than the proportion of serious adverse events fol-
lowing non-COVID-19 vaccines in 2021 (6.5%) and
than that reported in the US Vaccine Adverse Event
Reporting System (VAERS).
"Reports of a fatal outcome following COVID-19 vac-
cination were rare, and mostly occurred in people
aged 60 years and over"
"the median age at death following COVID-19 vaccination in AEMS (76 years) was similar to the median age of all deaths in 2021 (79.1 years)"
#Australia
#mRNA
#COVIDVACCINE
"With large-scale vaccination programs and an increase in the number of people being vaccinated, it was likely that some people would experience a new illness or die, from any cause, in the days to weeks following vaccination."
Absolutely vile 🤬
#Australia
#mRNA
#COVIDVACCINE
"The highest AESI reporting rates were observed
for myocarditis and/or pericarditis following
Comirnaty and Spikevax in adolescents and adults
aged 12–15 and 16–59 years, as well as thrombosis
and thromboembolism and thrombocytopenia fol-
lowing Vaxzevria in people aged 16–59 and ≥ 60
years. While these AESI reports reflected true safety
signals that prompted further investigation by the
TGA, they were also common events in older adult-
hood (in particular thrombosis and thromboem-
bolism and thrombocytopenia), and some of these
reports were likely to be coincidental."
#Australia
#mRNA
#COVIDVACCINE
Here is a list of potential adverse events for COVID-19 vaccines which is still under monitoring at the end of 2021 👇🏽
#Australia
#mRNA
#COVIDVACCINE
Here is a list of the 50 most frequently reported adverse events.
#Australia
#mRNA
#COVIDVACCINE
Here is a list of adverse events of special interest (AESI) reported in reports of adverse events following immunisation with COVID-19 vaccines in AEMS.
This list should be enough to re-call this dangerous product from the Australian market.
#Australia
#mRNA
#COVIDVACCINE
Age distribution and median time to death for reports of death following immunisation with COVID-19 vaccines in the Adverse Event Management System.
NINE MONTHS have passed since .@SenatorRennick and .@Jikkyleaks called out the Office of Gene Technology Regulator (OGTR), which is part of Dept. of health Australia on their position of why COVID-19 mRNA vaccines are not Gene Therapy and the regulators convoluted response implying it is - they are still crying 'misinformation'.
Here is there latest (26 June 2024) statement on mRNA COVID-19 vaccines are not gene therapies.
The Office of Gene Technology Regulator (OGTR) issued a similar statement on 6 December 2023, after the exchange (next tweet) between .@SenatorRennick and Raj Bhula (current OGTR regulator) from Senate Estimates hearing blew up in social media.
Those who are not aware, this stems from the iconic thread shared by .@Jikkyleaks where .@SenatorRennick called out Dr. Raj Bhula who is the current regulator (OGTR).
Dept. of Health Australia has updated their Guidance on Myocarditis and Pericarditis after COVID-19 vaccines on 12 January 2024.
Here are some interesting points 👇🏽
#Australia
#CovidVaccines
In the guidance published on 9 Nov 2022, they said that a small number of cases of have been reported in the clinical trial and in Australia. Now, they are saying that Myocarditis and/or pericarditis can occur after Novavax at a similar rate to the mRNA vaccine.
Myocarditis - 4 in every 100K doses.
Pericarditis - 13 in every 100K doses.
The Office of Gene Technology Regulator (OGTR), which is part of Dept. of health #Australia is crying 'misinformation' because .@SenatorRennick & .@Jikkyleaks called them out on their BS on mRNA vaccines and 'transfection'.
Those who are not aware, please refer to this iconic thread shared by .@Jikkyleaks where .@SenatorRennick questioned Dr Raj Bhula who is the current Regulator (OGTR) and has over 20 years’ experience in the regulation of pesticides in Australia.
Their statement reads:
'transfect' - It 'may' also mean ‘enter into the cell’s
nucleus to stably integrate in the genome’. This is a meaning that DOES NOT apply to the two mRNA vaccine.
How can they say it, as @Jikkyleaks pointed out so rightly 👇🏽
The notes from the Australian senate committee supplementary budget estimates 2021- 2022 on #Ivermectin are stunning.
A 🧵
#Ivermectin
#Australia
One of the key reason to restrict prescribing #Ivermectin was that people would have taken ivermectin to treat or prevent COVID-19 infection rather than getting vaccinated.
#Australia
Did you know that the decision to restrict prescribing of #ivermectin was not open to public consultation.
The risk they are highlighting which is spreading of COVID-19 in the community.
Please note that that COVID-19 vaccine never prevented transmission.
In late 2022, as part of the process of should the restriction on #Ivermectin be lifted in Australia, The NSW Poisons Information centre (NSW PIC) in their submission to the TGA advised that they were not in favor.
#Ivermectin
#Australia
This is because since restriction was applied, they had 35 calls regarding exposures to ivermectin which was being inappropriately used for Covid treatment or prevention.
#Ivermectin
#Australia
How the use of vet products indicated the restrictions (of ivermectin) in prescribing working?
The restriction forced people to obtain #Ivermectin illegally or to use ivermectin manufactured for animals. The prohibition produced the opposite desired impact.
In Jan 2021, when TGA "Provisionally" approved ASTRAZENECA COVID-19 vaccine, they knew the following:-
1. Bio-distribution study was pending. 2. Vaccine long term immunity was a concern & not assessed. 3. Booster didn't provide better protection. https://t.co/DEKZ6Uusuqtwitter.com/i/web/status/1…
4. Did you know there were concerns for Anti-ChAd vector antibodies due to repeat vaccination?
On 9 Feb 2022, TGA #Australia provisionally approved AstraZeneca's COVID-19 vaccine as booster dose.
6. This report was authorized on 28 Jan 2021.
They knew that Antibodies generally declined quickly over 2 weeks after the booster dose and yet on 9 Feb 2022 (an year later), TGA "provisionally" approved AstraZeneca's COVID-19 vaccine as booster dose.